Novo Nordisk shares drop 15% after poor trial results for new obesity drug

All NewsFebruary 23, 2026

Once-a-week injection achieved less weight loss than rival treatment

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent